{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:06:02Z","timestamp":1773147962047,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.jns.2011.03.031","type":"journal-article","created":{"date-parts":[[2011,4,21]],"date-time":"2011-04-21T00:48:13Z","timestamp":1303346893000},"page":"115-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Preventive and therapeutic effects of the selective Rho-kinase inhibitor fasudil on experimental autoimmune neuritis"],"prefix":"10.1016","volume":"306","author":[{"given":"Arnold Angelo M.","family":"Pineda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motozumi","family":"Minohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobutoshi","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojia","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Piao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Shimokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-ichi","family":"Kira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2011.03.031_bb0005","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/277140a0","article-title":"Identification of the neuritogen for experimental allergic neuritis","volume":"277","author":"Kadlubowski","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.jns.2011.03.031_bb0010","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0022-510X(87)90235-8","article-title":"P0 myelin protein produces experimental allergic neuritis in Lewis rats","volume":"79","author":"Milner","year":"1987","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2011.03.031_bb0015","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0165-5728(90)90068-X","article-title":"New minimum length requirement for a T cell epitope for experimental allergic neuritis","volume":"27","author":"Olee","year":"1990","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2011.03.031_bb0020","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/mus.880180202","article-title":"Toyka KV. Immunopathogenesis and treatment of the Guillain \u2013 Barre syndrome: Part I","volume":"18","author":"Hartung","year":"1995","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2011.03.031_bb0025","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-0404.1994.tb02674.x","article-title":"Th1-like cell responses to peripheral nerve myelin components over the course of experimental allergic neuritis in Lewis rats","volume":"90","author":"Zhu","year":"1994","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.jns.2011.03.031_bb0030","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF00792612","article-title":"Autoimmune response in peripheral nerve","volume":"18","author":"Hartung","year":"1996","journal-title":"Springer Semin Immunopathol"},{"key":"10.1016\/j.jns.2011.03.031_bb0035","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0165-5728(97)00238-5","article-title":"Cytokine production and the pathogenesis of experimental autoimmune neuritis and Guillain \u2013 Barre syndrome","volume":"84","author":"Zhu","year":"1998","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2011.03.031_bb0040","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0165-5728(99)00195-2","article-title":"Pathogenesis of Guillain\u2013Barre syndrome","volume":"100","author":"Hughes","year":"1999","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2011.03.031_bb0045","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0022-510X(92)90069-W","article-title":"T cell responses to myelin in Guillain-Barr\u00e9 syndrome","volume":"111","author":"Khalili-Shirazi","year":"1992","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2011.03.031_bb0050","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1084\/jem.20021425","article-title":"Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin","volume":"197","author":"Aktas","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.jns.2011.03.031_bb0055","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1096\/fj.02-1014fje","article-title":"Lovastatin inhibits brain endothelial cell Rho-mediated lymphocyte migration and attenuates experimental autoimmune encephalomyelitis","volume":"17","author":"Greenwood","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.jns.2011.03.031_bb0060","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.4049\/jimmunol.172.2.1273","article-title":"Potential targets of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor for multiple sclerosis therapy","volume":"172","author":"Nath","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.jns.2011.03.031_bb0065","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0304-3940(99)00414-0","article-title":"Amelioration of experimental allergic encephalomyelitis in Lewis rats by lovastatin","volume":"269","author":"Stanislaus","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jns.2011.03.031_bb0070","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nature01158","article-title":"The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease","volume":"420","author":"Youssef","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jns.2011.03.031_bb0075","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S1474-4422(04)00770-7","article-title":"Are statins a treatment option for multiple sclerosis?","volume":"3","author":"Neuhaus","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jns.2011.03.031_bb0080","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1006\/excr.2000.5046","article-title":"Regulation and functions of Rho-associated kinase","volume":"261","author":"Amano","year":"2000","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jns.2011.03.031_bb0085","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0165-6147(00)01596-0","article-title":"Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of non-muscle cells","volume":"22","author":"Fukata","year":"2001","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jns.2011.03.031_bb0090","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1161\/01.ATV.0000176193.83629.c8","article-title":"Rho-kinase is an important therapeutic target in cardiovascular medicine","volume":"25","author":"Shimokawa","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jns.2011.03.031_bb0095","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.4049\/jimmunol.168.8.4087","article-title":"Inhibition of Rho GTPases with protein prenyltransferase inhibitors prevents leukocyte recruitment to the central nervous system and attenuates clinical signs of disease in an animal model of multiple sclerosis","volume":"168","author":"Walters","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jns.2011.03.031_bb0100","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1084\/jem.20040819","article-title":"Flavonoids influence monocytic GTPase activity and are protective in experimental allergic encephalitis","volume":"200","author":"Hendriks","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.jns.2011.03.031_bb0105","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jneuroim.2006.06.027","article-title":"The selective Rho-kinase inhibitor Fasudil is protective and therapeutic in experimental autoimmune encephalomyelitis","volume":"180","author":"Sun","year":"2006","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2011.03.031_bb0110","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1582-4934.2007.00004.x","article-title":"Expression of RhoA by inflammatory macrophages and T cells in rat experimental autoimmune neuritis","volume":"11","author":"Zhang","year":"2007","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.jns.2011.03.031_bb0115","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1034\/j.1399-0039.2001.057005447.x","article-title":"Differences between T-cell reactivities to major myelin protein-derived peptides in opticospinal and conventional forms of multiple sclerosis and healthy controls","volume":"57","author":"Minohara","year":"2001","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jns.2011.03.031_bb0120","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/brain\/awh453","article-title":"Intrathecal activation of the IL-17\/IL-8 axis in opticospinal multiple sclerosis","volume":"128","author":"Ishizu","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.jns.2011.03.031_bb0125","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1161\/01.RES.0000096650.91688.28","article-title":"Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P)H oxidase system","volume":"93","author":"Higashi","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.jns.2011.03.031_bb0130","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jns.2005.03.015","article-title":"Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss","volume":"233","author":"Petzold","year":"2005","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2011.03.031_bb0135","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2169\/internalmedicine.31.6","article-title":"Immunosuppressive effect of FK506 on experimental allergic neuritis in Lewis rats: change of T cell subsets","volume":"31","author":"Adachi","year":"1992","journal-title":"Intern Med"},{"key":"10.1016\/j.jns.2011.03.031_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-5728(00)00249-6","article-title":"Experimental allergic neuritis in the SJL\/J mouse: induction of severe and reproducible disease with bovine peripheral nerve myelin and pertussis toxin with or without interleukin-12","volume":"107","author":"Calida","year":"2000","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2011.03.031_bb0145","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/89058","article-title":"Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site","volume":"7","author":"Weitz-Schmidt","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.jns.2011.03.031_bb0150","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/S1567-5769(03)00184-X","article-title":"Comparison of effects of Y-27632 and Isoproterenol on release of cytokines from human peripheral T cells","volume":"3","author":"Aihara","year":"2003","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jns.2011.03.031_bb0155","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1034\/j.1600-065X.2002.18910.x","article-title":"The distal pole complex: a novel membrane domain distal to the immunological synapse","volume":"189","author":"Cullinan","year":"2002","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jns.2011.03.031_bb0160","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S1074-7613(01)00224-2","article-title":"ERM-dependent movement of CD43 defines a novel protein complex distal to the immunological synapse","volume":"15","author":"Allenspach","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.jns.2011.03.031_bb0165","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1006\/cimm.1995.1187","article-title":"Synergistic effect of IFN-\u03b3 and TNF-\u03b1 on expression of immune molecules and antigen presentation by Schwann cell","volume":"165","author":"Gold","year":"1995","journal-title":"Cell Immunol"},{"key":"10.1016\/j.jns.2011.03.031_bb0170","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.atherosclerosis.2009.04.025","article-title":"Effects of fasudil on early atherosclerotic plaque formation and established lesion progression in apolipoprotein E-knockout mice","volume":"207","author":"Wu","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jns.2011.03.031_bb0175","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/FJC.0b013e318064f150","article-title":"Fasudil attenuates myocardial fibrosis in assocation with inhibition of monocyte\/macrophage infiltration in the heart of DOCA\/salt hypertensive rats","volume":"50","author":"Ishimaru","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jns.2011.03.031_bb0180","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrd1719","article-title":"Rho kinase, a promising drug target for neurological disorders","volume":"4","author":"Mueller","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jns.2011.03.031_bb0185","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1083\/jcb.200405002","article-title":"Regulation of SNAREs by tomosyn and ROCK: implication in extension and retraction of neurites","volume":"166","author":"Sakisaka","year":"2004","journal-title":"J Cell Biol"},{"key":"10.1016\/j.jns.2011.03.031_bb0190","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s007010050260","article-title":"Intra-arterial infusion of fasudil hydrochloride for treating vasospasm following subarachnoid haemorrhage","volume":"141","author":"Tachibana","year":"1999","journal-title":"Acta Neurochir Wien"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X11001614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X11001614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T15:40:49Z","timestamp":1758382849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X11001614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":38,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0022510X11001614"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2011.03.031","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preventive and therapeutic effects of the selective Rho-kinase inhibitor fasudil on experimental autoimmune neuritis","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2011.03.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}